Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 15 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Imprialos, Konstantinos [Clear All Filters]
Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of RCTs..
Diabetes Res Clin Pract. 158, 107927.
(2019).
(2019).
(2019). Introducing In Vivo Dissection Modules for Undergraduate Level Trainees: What Is the Actual Benefit and How Could We Make It More Efficient?.
Indian J Surg. 80(1), 68-76.
(2018). Pseudohyperaldosteronism due to mumijo consumption during pregnancy: a licorice-like syndrome..
Gynecol Endocrinol. 34(12), 1019-1021.
(2018). Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?.
Open Cardiovasc Med J. 12, 29-40.
(2018). What is the role of statins in the elderly population?.
Expert Rev Clin Pharmacol. 11(4), 329-331.
(2018). Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?.
Curr Vasc Pharmacol. 15(1), 47-50.
(2017). Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun..
Curr Pharm Des. 23(10), 1540-1550.
(2017). Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?.
J Hypertens. 35(5), 950-952.
(2017). SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature..
Curr Pharm Des. 23(10), 1510-1521.
(2017). Depression in hypertensive patients: the role of comorbidities..
J Hypertens. 34(7), 1441.
(2016). Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive Function..
JAMA Intern Med. 176(3), 409.
(2016). Echocardiographic Parameters During Long and Short Interdialytic Intervals in Hemodialysis Patients..
Am J Kidney Dis. 68(5), 772-781.
(2016). PATHWAY-2: spironolactone for resistant hypertension..
Lancet. 387(10026), 1371-1372.
(2016).